Clinical Trial: The Effect of Vocal Rest Versus Vocalization Following Xeomin® Injections in Spasmodic Dysphonia

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional

Official Title: The Effect of Vocal Rest Versus Vocalization Following Xeomin® Injections in Spasmodic Dysphonia

Brief Summary: This study will compare the effects of vocal rest versus continuous vocalization for one hour immediately following botulinum toxin injections for adductor spasmodic dysphonia.

Detailed Summary:
Sponsor: Lawson Health Research Institute

Current Primary Outcome:

  • Severity of spasmodic dysphonia symptoms [ Time Frame: Six weeks post-treatment ]
    Acoustic measures and perceptual ratings of vocal spasm severity
  • Patient-reported outcome measures of symptoms and communication [ Time Frame: six weeks post-treatment ]
    Six patient-reported questionnaires related to symptoms, communication effectiveness, quality of life, and self-efficacy


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Lawson Health Research Institute

Dates:
Date Received: April 19, 2017
Date Started: May 23, 2017
Date Completion: May 1, 2019
Last Updated: April 21, 2017
Last Verified: April 2017